2m 2m 2m 2m 2m 2m 2m
AVALO THERAP (AVTX)
NASDAQ
$13.90-$0.06 (-0.43%)
Price as of Jun 03, 2026 7:30 PM EDT- $838.4MMarket Cap
- 217.27%1-Year Change
- BiotechnologyIndustry
AVALO THERAP (AVTX)
$13.90-$0.06 (-0.43%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
ARMISTICE CAPITAL, LLC | 35.10% | 4.0M | 0 (0.00%) | Dec 31, 2022 |
FMR LLC | 25.50% | 2.9M | +2.7M (+92.35%) | Mar 31, 2026 |
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 19.15% | 2.2M | +2.2M (+100.00%) | Mar 31, 2026 |
CALIGAN PARTNERS LP | 14.48% | 1.6M | +753,490 (+46.08%) | Mar 31, 2026 |
BVF INC/IL | 14.46% | 1.6M | +277,588 (+17.00%) | Mar 31, 2026 |
STONEPINE CAPITAL MANAGEMENT, LLC | 13.37% | 1.5M | +660,095 (+43.71%) | Dec 31, 2021 |
AVORO CAPITAL ADVISORS LLC | 12.48% | 1.4M | +1.4M (+100.00%) | Mar 31, 2026 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
VANGUARD INDEX FUNDS | 23.98% | 2.7M | 0 (0.00%) | Mar 31, 2026 |
FIDELITY CONCORD STREET TRUST | 7.13% | 805,083 | 0 (0.00%) | Feb 28, 2026 |
FIDELITY SALEM STREET TRUST | 4.01% | 452,820 | 0 (0.00%) | Mar 31, 2026 |
COLLEGE RETIREMENT EQUITIES FUND | 2.14% | 242,233 | 0 (0.00%) | Mar 31, 2026 |
VANGUARD VARIABLE INSURANCE FUNDS | 2.10% | 237,319 | 0 (0.00%) | Mar 31, 2026 |
VANGUARD SCOTTSDALE FUNDS | 1.83% | 206,431 | 0 (0.00%) | Feb 28, 2026 |
TIAA-CREF FUNDS | 1.41% | 159,124 | 0 (0.00%) | Jan 31, 2026 |
Current Ownership Distribution
- Institutions245.7M (71.09%)
- Insiders50.4M (14.57%)
- Mutual Funds49.6M (14.34%)
- Other0 (0.00%)
Insider Transactions
- 14.57% (50.4M)Current InsiderOwnership (%, shares)
- 0Number of InsiderBuying (last 12 months)
- $0.00Amount of InsiderBuying (last 12 months)
- 5Number of InsiderSelling (last 12 months)
- $5.0MAmount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
Doyle Mittie Chief Medical Officer | Exempt | May 28, 2026 | $0.00 | 679 | $0.00 | 118,321 |
Doyle Mittie Chief Medical Officer | Exempt | May 28, 2026 | $5,459.16 | 679 | $8.04 | 47,801 |
Doyle Mittie Chief Medical Officer | Sell | May 28, 2026 | $10,864.00 | 679 | $16.00 | 47,122 |
Riley Jennifer Chief Strategy Officer | Award | May 21, 2026 | $0.00 | 34,200 | $0.00 | 36,855 |
Sullivan Christopher Ryan Chief Financial Officer | Award | May 21, 2026 | $0.00 | 39,900 | $0.00 | 40,323 |
VARKI PAUL Chief Legal Officer | Award | May 21, 2026 | $0.00 | 24,300 | $0.00 | 27,934 |
Doyle Mittie Chief Medical Officer | Award | May 21, 2026 | $0.00 | 43,500 | $0.00 | 47,122 |
NEIL GARRY ARTHUR Chief Executive Officer | Award | May 21, 2026 | $0.00 | 100,200 | $0.00 | 190,314 |
Sullivan Christopher Ryan Chief Financial Officer | Exempt | May 07, 2026 | $0.00 | 18,606 | $0.00 | 168,094 |
Sullivan Christopher Ryan Chief Financial Officer | Exempt | May 07, 2026 | $183,827.28 | 18,606 | $9.88 | 19,029 |
Sullivan Christopher Ryan Chief Financial Officer | Sell | May 07, 2026 | $448,817.65 | 18,606 | $24.12 | 423 |
Chan Mitchell | Sell | May 06, 2026 | $72,460.96 | 3,167 | $22.88 | 3,166 |
Sullivan Christopher Ryan Chief Financial Officer | Exempt | May 06, 2026 | $0.00 | 47,000 | $0.00 | 116,000 |
Sullivan Christopher Ryan Chief Financial Officer | Exempt | May 06, 2026 | $377,880.00 | 47,000 | $8.04 | 47,423 |
Sullivan Christopher Ryan Chief Financial Officer | Sell | May 06, 2026 | $256,655.29 | 13,834 | $18.55 | 33,589 |
Sullivan Christopher Ryan Chief Financial Officer | Sell | May 06, 2026 | $238,093.37 | 12,347 | $19.28 | 21,242 |
Sullivan Christopher Ryan Chief Financial Officer | Sell | May 06, 2026 | $56,052.00 | 2,700 | $20.76 | 18,542 |
Sullivan Christopher Ryan Chief Financial Officer | Sell | May 06, 2026 | $197,008.19 | 9,219 | $21.37 | 9,323 |
Sullivan Christopher Ryan Chief Financial Officer | Sell | May 06, 2026 | $200,913.05 | 8,900 | $22.57 | 423 |
VARKI PAUL Chief Legal Officer | Exempt | May 06, 2026 | $0.00 | 62,500 | $0.00 | 87,500 |
VARKI PAUL Chief Legal Officer | Exempt | May 06, 2026 | $0.00 | 12,563 | $0.00 | 87,437 |
VARKI PAUL Chief Legal Officer | Exempt | May 06, 2026 | $839,375.00 | 62,500 | $13.43 | 66,134 |
VARKI PAUL Chief Legal Officer | Exempt | May 06, 2026 | $101,006.52 | 12,563 | $8.04 | 78,697 |
VARKI PAUL Chief Legal Officer | Sell | May 06, 2026 | $706,836.00 | 37,375 | $18.91 | 41,322 |
VARKI PAUL Chief Legal Officer | Sell | May 06, 2026 | $102,783.12 | 5,196 | $19.78 | 36,126 |
VARKI PAUL Chief Legal Officer | Sell | May 06, 2026 | $484,540.80 | 22,839 | $21.22 | 13,287 |
VARKI PAUL Chief Legal Officer | Sell | May 06, 2026 | $210,029.22 | 9,253 | $22.70 | 4,034 |
VARKI PAUL Chief Legal Officer | Sell | May 06, 2026 | $9,484.00 | 400 | $23.71 | 3,634 |
Sullivan Christopher Ryan Chief Financial Officer | Sell | Apr 30, 2026 | $111,853.13 | 8,457 | $13.23 | 423 |
Sullivan Christopher Ryan Chief Financial Officer | Sell | Apr 29, 2026 | $110,736.37 | 8,458 | $13.09 | 8,880 |